Skip to main content

CVS Health: Guggenheim Sees “Sustainable and Visible Growth” Fueling 18% Upside

CVS Health ( CVS ) shares rallied 5% yesterday after the pharmacy benefits manager reported second quarter profit that beat estimates and lifted its full-year earnings forecast . But John Heinbockel at Guggenheim argues that the stock still has room to climb, citing a $115 price target.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.